Projects

Strategic Roadmap for Global Diversification

Goal: Transformed a domestically-focused R&D/manufacturing facility into an internationally diversified, commercially progressive growth engine.

​

Methodology: Authored a five-year strategic roadmap based on a 'bottoms-up' budget directly tied to securing new contracts and services.

​

Core Shift: Successfully shifted the organizational focus from capital investment to aggressive Commercial Pillar expansion.

A strategic consulting mandate was executed for a leading European pharmaceutical manufacturing group, focused on creating an accelerated, three-year growth and modernization roadmap.

Key Achievements:

​

Financial Growth: Developed a strategy to drive a 49.5% increase in total revenue, anchored by a plan to double export sales.

​

Digital Transformation: Defined the R&D and implementation path for a fully integrated ERP system to replace the client's obsolete platform while maintaining strict regulatory compliance.

​

Operational Investment: Recommended a €1 million capital expenditure for facility upgrades, creating 30 new jobs, and embedding continuous improvement (Lean) across the site.

​

Sustainability: Established a foundational plan for developing and implementing a full Scope 1, 2, and 3 decarbonisation strategy to future-proof operations..

We served as the overall Co-Ordinator for the External Advisor Programme during the EIT Health Business Plan 2021 Innovation Call.

 

The EIT Health Business Plan Innovation Call is a major initiative by the European Institute of Innovation and Technology (EIT) Health to drive healthcare innovation across Europe, aiming to fund high-quality projects that address key health challenges and rapidly penetrate the market with innovative products or services.

 

Our role involved managing the entire External Advisor network, including experts across Biotech, Medical Devices, Digital Health, and SOP, while also acting as the External Advisor Category Project Manager for Digital Health.

 

We provided direct, expert consultation to innovators, helping to shape and refine their proposals to meet EIT Health's rigorous standards and secure crucial funding for new European healthcare solutions.

Delivered a critical financial governance and P&L control overhaul to enable a family-owned manufacturing firm to target a 50% increase in net profit (from 10% to 15%). The project focused exclusively on implementing strict financial discipline:

​

Formalised P&L Control: Eliminated fragmented processes by implementing a high-priority plan for formal budgeting and key performance indicator (KPI) tracking.

Real-Time Reporting: Mandated weekly financial reporting of key metrics (sales, margin, cash contribution) to replace late, manual monthly accounts and give directors immediate visibility.

​

Strategic Investment: Established clear Return on Investment (ROI) criteria for all capital expenditure (CapEx) and sales investment, resolving executive conflict and strategically re-allocating underperforming cash reserves.

​

Digital Roadmap: Prioritised the digital discovery phase for a new, integrated ERP system to automate high-cost manual finance tasks and achieve paperless efficiency.

Client: EIT Health InnoStars (RIS Regions)

​

We delivered a high-impact Project Development Training programme for EIT Health InnoStars, focusing on accelerating MedTech and healthcare innovation in emerging EU regions.

 

The core of our programme was shifting participants from an "Ideas First" mindset to a rigorous "Needs First Approach". This methodology ensures solutions are derived directly from unmet clinical needs, radically improving the design, development, and commercial viability of new concepts and addressing a common failure point in new product development.

 

The program was highly successful, with participants praising the practical workshops that applied innovation theory directly to their live projects.

Summary: This engagement began as a Feasibility Study commissioned by the RCSI for their "Vertigo" project, which had secured an Enterprise Ireland grant. Our role was to provide the critical commercial groundwork, including: Market Analysis / Commercial Strategy /Licensing & Finance: 

​

Evolution to a Business (Vertigenius)
The project successfully evolved into the MedTech spin-out company, Vertigenius™.

Product: Vertigenius developed a comprehensive digital platform that includes a wearable head sensor and a smartphone app. This system allows clinicians to remotely prescribe, deliver, and monitor customised vestibular rehabilitation exercises for patients suffering from vertigo, dizziness, and imbalance.

​

Scale and Funding: The company,  has successfully secured over €2.1 million in an oversubscribed seed funding round led by Atlantic Bridge and supported by Enterprise Ireland. This funding is being used to accelerate development, expand the team, and support market penetration into the UK and US.